RankingsPricing
  1. JP-listed companies
  2. Astellas Pharma Inc.
  3. Financials
  4. Marketable securities, non-current

Astellas Pharma Inc.【JP:4503】

Market cap
¥4.05T
P/E ratio
22.3x
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndMarketable securities, non-current (Million JPY)YoY (%)
Mar 31, 2025106,195-2.30%
Mar 31, 2024108,694+11.04%
Mar 31, 202397,886+6.58%
Mar 31, 202291,844-4.18%
Mar 31, 202195,850+29.07%
Mar 31, 202074,264-8.83%
Mar 31, 201981,457+143.77%
Mar 31, 201833,415+11.44%
Mar 31, 201729,985-42.19%
Mar 31, 201651,868-24.25%
Mar 31, 201568,476

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)